Artemis Medicare Reports Mixed Financial Results with Strong Inventory Management and Concerns on Non-Operating Income
Artemis Medicare Services has announced its financial results for the quarter ending December 2024, highlighting strong inventory turnover and a significant increase in profit after tax. The company maintains a low debt-equity ratio, though concerns arise regarding the sustainability of its non-operating income.
Artemis Medicare Services has recently reported its financial results for the quarter ending December 2024, showcasing a mix of positive developments and areas of concern. The company has experienced a notable performance in its inventory turnover ratio, achieving a high of 90.41 times over the last five half-year periods, indicating an efficient inventory management strategy. Additionally, the profit after tax (PAT) for the quarter stands at Rs 20.67 crore, reflecting a growth of 27.9% compared to the average PAT of the previous four quarters.On the balance sheet front, Artemis Medicare has maintained a low debt-equity ratio of 0.40 times, suggesting a prudent approach to borrowing relative to its equity capital. However, the company has also reported its highest non-operating income in the last five quarters at Rs 8.80 crore, raising questions about the sustainability of this income stream, as it stems from non-business activities.
In light of these developments, there has been an adjustment in evaluation for Artemis Medicare, reflecting the complexities of its financial landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
